Cookie Hinweis

Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .

Essentiell

Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Name Webedition CMS
Zweck Dieses Cookie wird vom CMS (Content Management System) Webedition für die unverwechselbare Identifizierung eines Anwenders gesetzt. Es bietet dem Anwender bessere Bedienerführung, z.B. Speicherung von Sucheinstellungen oder Formulardaten. Typischerweise wird dieses Cookie beim Schließen des Browsers gelöscht.
Name econda
Zweck Session-Cookie für die Webanalyse Software econda. Diese läuft im Modus „Anonymisiertes Messen“.
Statistik

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Name econda
Zweck Measure with Visitor Cookie emos_jcvid
Externe Medien

Inhalte von externen Medienplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

Name YouTube
Zweck Zeige YouTube Inhalte
Name Twitter
Zweck Twitter Feeds aktivieren

Defects in the packaging of genetic material in malignant brain tumors

No. 04 | 30/01/2012 | by Koh

Glioblastomas are regarded as particularly aggressive brain tumors. In children with glioblastoma, Heidelberg scientists have now discovered genetic alterations that affect the function of DNA packaging proteins known as histones. In a cell, histones serve as coils around which the DNA wraps. At the same time, histones regulate gene activity. Mutations in histone genes have never before been tied to a disease. The group comprising scientists of the German Cancer Research Center, Heidelberg University Hospitals and McGill University in Canada have now reported their findings in Nature.

DNA wrapped around histon proteins. Image: Emw, Wikimedia Commons

Glioblastomas grow extremely aggressively into healthy brain tissue and, moreover, are highly resistant to radiation therapy and chemotherapy. Therefore, they are regarded as the most malignant type of brain tumor. Currently available treatment methods are frequently not very effective against this type of cancer. Glioblastoma can affect people of all ages, but is less common in children than in adults.

In order to gain a better understanding of the molecular processes involved in the development of such tumors and, in this way, be able to develop novel treatment approaches, an international research team has now deciphered the genetic material of 48 pediatric glioblastomas. Project leaders have been Dr. Stefan Pfister of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg, Germany and Nada Jabado of McGill University in Montreal, Canada.

In almost one out of two cases the team discovered genetic alterations that affect certain proteins known as histones. These are the proteins around which the DNA molecule, a thread of several feet, coils inside cells. In some cases it was the histone genes themselves that were found altered, in other cases the alterations affected the genes coding for two other proteins that assist in wrapping the DNA around the histone coils.

The histone mutations are most prevalent in pediatric tumors (36 percent), while in adult glioblastoma they occur only very rarely (3 percent) and were not found at all in less aggressive brain tumors.

Histones are evolutionary highly conserved proteins which are much the same in man, mouse or threadworm. Up until recent years, histones were believed to be little more than DNA packaging material. However, by now it is known that they also determine which genes are read and which are not read; thus, they actively participate in regulating cell functions. A multitude of chemical tags at specific positions of a histone determine whether or not a gene can be accessed.

“The mutations we discovered tend to affect particularly those regions of the histone that regulate gene activity. Therefore, tumor cells with histone mutations have an altered gene activity profile,” says Stefan Pfister, who is a pediatrician and molecular biologist, and he further explains: “We have discovered the first histone mutation that is implicated in a disease. A single small histone defect can result in major changes in gene activity and, moreover, affect a cell’s life span – these two effects together can lead to cancer.”

A treatment approach known as epigenetic therapy, which influences the chemical tags of histones, is already being tested for the treatment of other types of cancer. The doctors and scientists of Pfister’s department will now investigate whether these drugs may also be effective against glioblastoma with histone defects.

This research project was funded by the German Ministry of Education and Research (BMBF) and German Cancer Aid (Deutsche Krebshilfe e. V.) as part of the funding of the German “PedBrain Tumor” project within the International Cancer Genome Consortium (ICGC) (€15 million over a 5-year period).

Jeremy Schwartzentruber*, Andrey Korshunov*, Xiao-Yang Liu*, David TW Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes, Volker Hovestadt, Steffen Albrecht, Marcel Kool, Andre Nantel, Carolin Konermann, Anders Lindroth, Natalie Jäger, Tobias Rausch, Marina Ryzhova, Jan O. Korbel, Thomas Hielscher, Peter Hauser, Miklos Garami, Almos Klekner, Laszlo Bognar, Martin Ebinger, Martin U. Schuhmann, Wolfram Scheurlen, Arnulf Pekrun, Michael C. Frühwald, Wolfgang Roggendorf, Christoph Kramm, Matthias Dürken, Jeffrey Atkinson, Pierre Lepage, Alexandre Montpetit, Magdalena Zakrzewska, Krzystof Zakrzewski, Pawel P. Liberski, Zhifeng Dong, Peter Siegel, Andreas E. Kulozik, Marc Zapatka, Abhijit Guha, David Malkin, Jörg Felsberg, Guido Reifenberger, Andreas von Deimling, Koichi Ichimura, V. Peter Collins, Hendrik Witt, Till Milde, Olaf Witt, Cindy Zhang, Pedro Castelo-Branco, Peter Lichter, Damien Faury, Uri Tabori, Christoph Plass, Jacek Majewski, Stefan M. Pfister, Nada Jabado: Exome sequencing identifies frequent driver mutations in histone H3.3 and ATRX-DAXX in paediatric glioblastoma.
Nature, January 29, 2012, DOI: 10.1038/nature10833

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS